文献速递眼底病与葡萄膜炎

视功能与通用生活质量量表对葡萄膜炎眼部和全身事件的反应性

Responsiveness of Vision-Specific and General Quality of Life Metrics to Ocular and Systemic Events in Patients with Uveitis.
PubMed 文献 · Ophthalmology · 2020-07-24

本研究基于MUST试验及随访研究数据,评估NEI-VFQ-25、EQ-5D和SF-36对非感染性葡萄膜炎患者眼部和全身事件的反应性。结果显示NEI-VFQ-25对眼部变化更敏感,而通用量表对急性全身事件更敏感,选择QoL测量工具时需考虑预期结局类型。

要点

  • NEI-VFQ-25对视力变化、植入物放置、白内障手术及炎症静止等眼部事件敏感。
  • EQ-5D对视力下降、需处方感染的感染及葡萄膜炎活动复发敏感。
  • SF-36 PCS对住院、需处方感染的感染及玻璃体出血敏感。

核心结论

  • NEI-VFQ-25对眼部变化比通用QoL量表更敏感,但对急性全身事件敏感性较低。
  • 进行QoL或成本效果分析时,应考虑预期结局是眼部还是全身,以确保所选测量工具能检测到临床重要变化。

研究设计与样本

  • 基于多中心葡萄膜炎类固醇治疗(MUST)试验及随访研究的队列研究,纳入活动性或近期活动的中间型、后型或全葡萄膜炎患者。
  • 在前3年内每半年评估NEI-VFQ-25、EQ-5D和SF-36,采用广义估计方程分析眼部和全身事件对6个月QoL变化的影响。

主要发现

  • 视力每变化5个字母,NEI-VFQ-25调整变化为2.70单位(P<0.001);至少1眼植入物放置调整变化为5.50(P<0.001);白内障手术调整变化为3.01(P=0.017); interval开始时所有活动眼静止调整变化为2.20(P<0.010)。
  • 视力每下降5个字母,EQ-5D指数调整变化为-0.014(P=0.003);需处方感染的感染调整变化为-0.024(P=0.021);至少1眼葡萄膜炎活动复发调整变化为-0.023(P=0.031)。
  • 住院调整变化为-2.24(P=0.019)、需处方感染的感染调整变化为-1.00(P=0.024)、至少1眼玻璃体出血调整变化为-1.92(P=0.021)与SF-36 PCS下降相关。
  • 视力下降、开始使用降眼压药物和年龄与SF-36 PCS变化相关,但变化幅度小于1分。

临床怎么用

  • 评估葡萄膜炎患者眼部相关生活质量时优先选用NEI-VFQ-25。
  • 评估全身事件或成本效果时需结合通用QoL量表如EQ-5D或SF-36 PCS。
  • 根据预期临床结局选择对相应事件敏感的QoL测量工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the responsiveness of quality of life (QoL) metrics to ocular and systemic events in patients with noninfectious uveitis. DESIGN: Cohort study using randomized controlled trial data. PARTICIPANTS: Patients with active or recently active intermediate, posterior, or panuveitis enrolled in the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. METHODS: Data on the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25), EuroQol Questionnaire (EQ-5D), and Short Form Survey Instrument (SF-36) were evaluated semiannually during the first 3 years after randomization. The impact of ocular (e.g., changes in visual acuity [VA], activity status, cataract surgery) and systemic events (e.g., infections requiring treatment) on the 6-month changes in QoL was assessed for each metric using generalized estimating equations. MAIN OUTCOME MEASURES: The primary outcomes were the 6-month changes in vision-related (NEI-VFQ-25) and general health-related (EQ-5D index, SF-36 physical component summary [PCS]) QoL. RESULTS: Changes in VA (adjusted change [aΔ]: 2.70 units per 5 letter change, P < 0.001), implant placement in at least 1 eye (aΔ: 5.50, P < 0.001), cataract surgery (aΔ: 3.01, P = 0.017), and quieting of all eyes active at the beginning of the interval (aΔ: 2.20, P < 0.010) were associated with improvements in the NEI-VFQ-25. Reductions in VA (aΔ: -0.014 per 5 letter decline, P = 0.003), infections requiring a prescription (aΔ: -0.024, P = 0.021), and incident uveitis activity in at least 1 eye (aΔ: -0.023, P = 0.031) were associated with declines in the EQ-5D index. Hospitalization (aΔ: -2.24, P = 0.019), infections requiring a prescription (aΔ: -1.00, P = 0.024), and vitreous hemorrhage in at least 1 eye (aΔ: -1.92, P = 0.021) were associated with declines in the SF-36 PCS. Declines in VA, initiation in IOP medication, and age were associated with changes in SF-36 PCS; however, the magnitude of the change was less than a single point. CONCLUSIONS: The NEI-VFQ-25 was more sensitive to ocular changes than the general QoL metrics but less sensitive to acute systemic events. When performing QoL or cost-effectiveness analyses, it is important to consider the expected outcomes (e.g., ocular vs. systemic) to ensure that the selected measurement is sensitive enough to detect clinically important changes in disease status or effects of treatment.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Sugar EA, Burke AE, Venugopal V, et al. Responsiveness of Vision-Specific and General Quality of Life Metrics to Ocular and Systemic Events in Patients with Uveitis. Ophthalmology. 2020. PMID: 32717341. doi:10.1016/j.ophtha.2020.07.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。